Filed before 2025Filed 28 September 2020
ReNetX Bio, Inc. has sold $2.8M so far
ReNetX Bio, Inc., a biotech company based in New Haven, CT, has sold $2.8M so far in its equity round, according to a filing dated 28 September 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 28 September 2020
- First filed
- 2 December 2019
- Round
- Equity round (amended filing)
- Amount sold
- $2.8M
- Offering size
- $2.8M
- Investors so far
- 6
- Based in
- New Haven, CT
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 27% of the 1,744 tracked raises with an amount filed in 2020, and than 12% of the 152 in biotech.
ReNetX Bio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 28 Sep 2020 | Amended filing | $2.8M | This raise |
| 2 Dec 2019 | New filing | $1.35M | This raise |
More with WHIN on the board
- Episteme Prognostics, Inc.$5.09M
- Allyx Therapeutics, Inc.$26.4M
- AtlasXomics Inc.$3.9M
- IsoPlexis Corp$7.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.